APTN
Adaptin Bio, Inc.Company with tickers: APTN
CIK
1938571
CUSIP
00654M100
Website
https://www.adaptinbio.com
Investor Relations
https://ir.adaptinbio.com/
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2025-09-08 | Zook Anthony P. |
Director | Award | 109,847 |
| 2025-09-08 | Hewitt L Arthur |
Chief Development Officer | Award | 109,847 |
| 2025-09-08 | Riehle J Nick |
Director | Award | 109,847 |
| 2025-09-08 | Pedder Simon |
Director, Executive Chairman, 10% Owner | Award | 192,231 |
| 2025-09-08 | Roberts Michael J |
Director, President and CEO, 10% Owner | Award | 439,386 |
| 2025-09-08 | Gallagher Patrick Joseph |
Director | Award | 109,847 |
| 2025-09-08 | Maness Timothy |
Chief Financial Officer | Award | 192,231 |
| 2025-02-11 | Hewitt L Arthur |
Chief Development Officer | Other | 0 |
| 2025-02-11 | Riehle J Nick |
Director | Other | 0 |
| 2025-02-11 | Gallagher Patrick Joseph |
Director | Other | 0 |
| 2025-02-11 | Lucius Partners LLC |
10% Owner | Other | 1,750,000 |
| 2025-02-11 | Maness Timothy |
Chief Financial Officer | Other | 0 |
| 2025-02-11 | Zook Anthony P. |
Director | Other | 0 |
| 2023-10-09 | Pereira Nathan P. |
Director, President, CEO, CFO | Other | 0 |
Showing 1–14 of 14 transactions